Early diagnosis of invasive aspergillosis in infants and children

References

• Abbasi S, Shenep JL, Hughes WT, Flynn PM. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 1999; 29: 1210–1219
   PubMed Web of Science ®Google Scholar
• Steinbach WJ. Pediatric aspergillosis. Disease and treatment differences in children. Pediatr Infect Dis J 2005; 24: 358–364
   PubMed Web of Science ®Google Scholar
• Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155–169
   PubMed Web of Science ®Google Scholar
• Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med Mycol 2005; 43: S247–S259
   PubMed Web of Science ®Google Scholar
• Groll AH, Jaeger G, Allendorf A, et al. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis 1998; 27: 437–452
   PubMed Web of Science ®Google Scholar
• Shetty D, Giri N, Gonzalez CE, Pizzo PA, Walsh TJ. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997; 16: 216–221
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609–622
   PubMed Web of Science ®Google Scholar
• Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003; 33: 453–460
   PubMed Web of Science ®Google Scholar
• Allan BT, Patton D, Ramsey NK, Day DL. Pulmonary fungal infections after bone marrow transplantation. Pediatr Radiol 1988; 18: 118–122
   PubMed Web of Science ®Google Scholar
• Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993; 23: 177–180
   PubMed Web of Science ®Google Scholar
• Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000; 355: 423–424
   PubMed Web of Science ®Google Scholar
• Lee YR, Choi YW, Lee KJ, et al. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 2005; 78: 862–865
   PubMed Web of Science ®Google Scholar
• Kami M, Kishi Y, Hamaki T, et al. The value of the chest computed tomography halo sign in the diagnosis of invasive pulmonary aspergillosis. An autopsy-based retrospective study of 48 patients. Mycoses 2002; 45: 287–294
   PubMed Web of Science ®Google Scholar
• Horger M, Hebart H, Einsele H, et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?. Eur J Radiol 2005; 55: 437–444
   PubMed Web of Science ®Google Scholar
• Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15: 465–484
   PubMed Web of Science ®Google Scholar
• Florent M, Katsahian S, Vekhoff A, et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006; 193: 741–747
   PubMed Web of Science ®Google Scholar
• Sulahian A, Boutboul F, Ribaud P, et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91: 311–318
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898–1906
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913–916
   PubMed Web of Science ®Google Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003; 349: 2366–2367
   PubMed Web of Science ®Google Scholar
• Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with {beta}-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006; 44: 389–394
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004; 42: 4744–4748
   PubMed Web of Science ®Google Scholar
• Siemann M, Koch-Dorfler M, Gaude M. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998; 41: 373–377
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MASH, Klont RR, Warris A, Op den Camp HJM, Verweij PE. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen. detection. Lancet 2004; 363: 325–327
   PubMed Web of Science ®Google Scholar
• Warris A, Abrahamsen TG, Breuker IM, et al. Fungal antigenemia in premature neonates due to the presence of galactomannan and mannan in milk formulas [J-848]. 41st Annual Interscience Confeence Antimicrobial Agents Chemotherapy. American Society of Microbiology, Chicago, IL 2001
   Google Scholar
• Monique A, Mennink-Kersten SH, Ruegebrink D, et al. Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005; 43: 3925–3931
   PubMed Web of Science ®Google Scholar
• Talwalkar A, Kailasapathy K. The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp. Curr Issues Intest Microbiol 2004; 5: 1–8
   PubMedGoogle Scholar
• Phillips M, Kailasapathy K, Tran L. Viability of commercial probiotic cultures (L. acidophilus, Bifidobacterium sp., L. casei, L. paracasei and L. rhamnosus) in cheddar cheese. Int J Food Microbiol 2006; 108: 276–280
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Schaufele RL, Sein T, , et al. Reduced expression of galactomannan antigenemia in patients with invasive aspergillosis and chronic granulomatous disease or Job's syndrome (abstract 345). In: 40th Annual Meeting of Infectious Disease Society of America; Chicago IL: Infectious Disease Society of America; 2002.
   Google Scholar
• Obayashi T, Yoshida M, Mori T, et al. Plasma (1 ≥ 3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20
   PubMed Web of Science ®Google Scholar
• Pazos C, Ponton J, Del Palacio A. Contribution of (1 ≥ 3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005; 43: 299–305
   PubMed Web of Science ®Google Scholar
• Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1 ≥ 3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004; 42: 2733–2741
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1 ≥ 3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957–5962
   PubMed Web of Science ®Google Scholar
• Roilides E, Farmaki E, Evdoridou J, et al. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004; 23: 745–750
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199–205
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1 ≥ 3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654–659
   PubMed Web of Science ®Google Scholar
• Hachem RY, Boctour M, Daugherty T, et al. The utility of galactomannan enzyme immunoassay and (1,3) B-D glucan in the diagnosis of invasive fungal infections in cancer patients (M-161). 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC. 2005; 415
   Google Scholar
• Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (13)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. Microbiology 1995; 33: 3115–3118
   Web of Science ®Google Scholar
• Digby J, Kalbfleisch J, Glenn A, et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003; 10: 882–885
   PubMedGoogle Scholar
• Sambatakou H, Guiver M, Denning D. Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole. Eur J Clin Microbiol Infect Dis 2003; 22: 681–685
   PubMed Web of Science ®Google Scholar
• Strandberg GW. D-mannitol metabolism by Aspergillus candidus. J Bacteriol 1969; 97: 1305–1309
   PubMed Web of Science ®Google Scholar
• Francis P, Lee JW, Hoffman A, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis 1994; 169: 356–368
   PubMed Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Chi J, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005; 73: 635–637
   PubMed Web of Science ®Google Scholar
• Halliday C, Hoile R, Sorrell T, et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006; 132: 478–486
   PubMed Web of Science ®Google Scholar
• Scotter JM, Campbell P, Anderson TP, et al. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005; 37: 246–253
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Gunsilius E, Gastl G, et al. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses ; 48 Suppl. 2005; 1: 12–17
   Google Scholar
• Buchheidt D, Hummel M, Schleiermacher D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004; 125: 196–202
   PubMed Web of Science ®Google Scholar
• Challier S, Boyer S, Abachin E, Berche P. Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2004; 42: 844–846
   PubMed Web of Science ®Google Scholar
• Bialek R, Moshous D, Casanova JL, Blanche S, Hennequin C. Aspergillus antigen and PCR assays in bone marrow transplanted children. Eur J Med Res 2002; 7: 177–180
   PubMed Web of Science ®Google Scholar
• Millon L, Piarroux R, Deconinck E, et al. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol 2005; 43: 5097–5101
   PubMed Web of Science ®Google Scholar
• Kami M, Tanaka Y, Kanda Y, et al. Computed tomographic scan of the chest, latex agglutination test and plasma (1 ≥ 3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica 2000; 85: 745–752
   PubMed Web of Science ®Google Scholar